BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17102092)

  • 1. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
    Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
    Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
    Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
    Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
    Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.
    Brouwers FM; Gläsker S; Nave AF; Vortmeyer AO; Lubensky I; Huang S; Abu-Asab MS; Eisenhofer G; Weil RJ; Park DM; Linehan WM; Pacak K; Zhuang Z
    Endocr Relat Cancer; 2007 Jun; 14(2):463-71. PubMed ID: 17639059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.
    Eisenhofer G; Huynh TT; Elkahloun A; Morris JC; Bratslavsky G; Linehan WM; Zhuang Z; Balgley BM; Lee CS; Mannelli M; Lenders JW; Bornstein SR; Pacak K
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1223-33. PubMed ID: 18854424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of mRNA coding for the adrenaline-synthesizing enzyme phenylethanolamine-N-methyl transferase in adrenaline-secreting pheochromocytomas.
    Isobe K; Nakai T; Yashiro T; Nanmoku T; Yukimasa N; Ikezawa T; Suzuki E; Takekoshi K; Nomura F
    J Urol; 2000 Jan; 163(1):357-62. PubMed ID: 10604389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
    Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HP; Teh BT
    Oncogene; 2002 Feb; 21(7):1117-22. PubMed ID: 11850829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
    Assadi F; Brackbill EL
    Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.
    Ritter MM; Frilling A; Crossey PA; Höppner W; Maher ER; Mulligan L; Ponder BA; Engelhardt D
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1035-7. PubMed ID: 8772572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
    Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile.
    Powers JF; Evinger MJ; Zhi J; Picard KL; Tischler AS
    Neuroscience; 2007 Jul; 147(4):928-37. PubMed ID: 17582688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylethanolamine-N-methyltransferase activity determines the epinephrine concentration of pheochromocytomas.
    Feldman JM
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):389-98. PubMed ID: 7323441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.
    Mircescu H; Wilkin F; Paquette J; Oligny LL; Decaluwe H; Gaboury L; Nolet S; Van Vliet G; Deal C
    J Pediatr; 2001 Feb; 138(2):269-73. PubMed ID: 11174629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
    Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
    Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.
    Eisenhofer G; Vocke CD; Elkahloun A; Huynh TT; Prodanov T; Lenders JW; Timmers HJ; Benhammou JN; Linehan WM; Pacak K
    Horm Metab Res; 2012 May; 44(5):343-8. PubMed ID: 22438210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.